Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory.
Authors: Gupta Ramesh C, Lall Rajiv, Srivastava Ajay, Sinha Anita
Journal: Frontiers in veterinary science
Summary
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found throughout the body, with particular abundance in articular cartilage and synovial fluid, where it contributes significantly to joint lubrication and viscoelastic properties essential for normal biomechanics. Gupta and colleagues conducted a comprehensive review examining the molecular mechanisms by which HA exerts therapeutic effects across multiple disease states, with particular emphasis on osteoarthritis (OA), noting that HA concentrations and molecular weight decline progressively during arthritic degeneration and ageing. The authors identified that HA functions through multiple pathways involving receptor interactions, enzymatic modulation, and metabolic signalling rather than through a single mechanism, and critically, demonstrated that the molecular weight profile of HA formulations significantly influences their therapeutic efficacy—a distinction often overlooked in clinical practice. With over four decades of clinical application in equine, canine and human medicine, HA represents a well-established intervention for OA management, and the review extends beyond joint disease to encompass emerging applications in ophthalmic, dermal and wound-healing contexts. For equine professionals, these findings underscore the importance of selecting HA products formulated with appropriate molecular weight ranges for specific conditions and highlight the biological rationale supporting intra-articular therapy, whilst also suggesting potential utility in integrative protocols addressing secondary tissue damage associated with chronic joint disease.
Read the full abstract on PubMed
Practical Takeaways
- •HA is an evidence-based therapeutic option for managing joint disease in horses; understanding that molecular weight matters will help you select appropriate products for your patients
- •HA works through multiple biological pathways to reduce arthritic changes, not just as a lubricant—this supports its use early in joint disease before significant cartilage loss occurs
- •HA's broad therapeutic applications beyond joints (wound healing, ophthalmology, dermatology) may offer additional clinical opportunities in equine practice
Key Findings
- •Hyaluronic acid concentration and molecular weight decline with osteoarthritis progression and aging across multiple species including horses, dogs, and humans
- •HA exerts anti-arthritic effects through multiple mechanisms involving receptors, enzymes, and metabolic pathways rather than through a single mechanism
- •Molecular weight of HA is critical to therapeutic efficacy and must be considered in product formulation design
- •HA has been successfully used clinically for over 40 years in treating osteoarthritis due to its role in synovial fluid lubrication and viscoelasticity